Two Sigma Investments, LP Impel Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.86 - $9.85 $832,694 - $1.4 Million
-142,098 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.33 - $12.14 $1.18 Million - $1.73 Million
142,098 New
142,098 $1.23 Million
Q3 2021

Nov 15, 2021
SELL
$8.38 - $26.13 $84,160 - $262,423
-10,043 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$7.33 - $15.2 $73,615 - $152,653
10,043 New
10,043 $89,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email